P. Dipiro

Large-core needle biopsy of nonpalpable breast lesions.

J. Meyer, D. Smith, S. Lester, 1999, JAMA.

Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

A. D. Van den Abbeele, A. Giobbie-Hurder, M. Mihm, 2014, Cancer Immunology Research.

Radiology Consultation in the Era of Precision Oncology: A Review of Consultation Models and Services in the Tertiary Setting

P. Dipiro, Marta Braschi-Amirfarzan, N. Ramaiya, 2017, Korean journal of radiology.

Staging Workup in Pregnant Cancer Patients

P. Dipiro, E. Mayer, A. O’Neill, 2016 .

A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer

E. Winer, R. Gelman, N. Lin, 2013, Breast Cancer Research and Treatment.

Marked regression of a nonpalpable breast cancer after cessation of hormone replacement therapy.

J. Meyer, P. Dipiro, S. Harvey, 1996, AJR. American journal of roentgenology.

Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG‐PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade

Su-Chun Cheng, J. Bellon, B. Overmoyer, 2019, Clinical breast cancer.

Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.

A. Ng, M. Hunink, P. Dipiro, 2014, International journal of radiation oncology, biology, physics.

CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool.

A. D. Van den Abbeele, P. Jänne, J. Yap, 2011, Academic radiology.